This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer\<10 mIU/mL) need to take.
Age range
20 Years – 36 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
anti-HBs titer response rate at 7-10 days
Timeframe: 7-10 days
anti-HBs titer response rate at one month
Timeframe: 28 days
anti-HBs titer response rate at 6 months
Timeframe: 24-28 weeks
anti-HBs titer response rate at 12 months
Timeframe: 48-52 weeks
anti-HBs titer immune response change at 12 months
Timeframe: 48-52 weeks